British Monitoring Zyban
May 18, 2001
According to GlaxoSmithKline and the UK Department of Health, at present there is no link between reports of 18 deaths and the use of Zyban. "The contribution of Zyban to these deaths is unknown," commented the department.
After the U.S. Food and Drug Administration approved Zyban in July 2000, several British general practitioners reported Zyban related deaths to the UK Medicines Control Agency (MCA). This was part of an "intensive monitoring exercise" created by the MCA to examine the safety and effectiveness of Zyban.
Concerns about the prescription drug are still growing, as more reports of adverse reactions are being brought to the attention of GlaxoSmithKline and and government agencies. The company still contends that there is no link between the reports of death and Zyban.
-- Article Courtesy of InjuryBoard.com
More ...
.